Table 2.

Characteristics of the malaria patients who developed severe sequelae

Patient	Country of acquisition	Malaria species	Parasitemia (%)	Disease severity	Antimalarial regimen	Sequelae
54 M, Japanese	Senegal	Pf	10.1	Severe	IV artesunate, mefloquine	Post-malaria neurological syndrome
29 F, Japanese	Ghana	Pf	12.1	Severe	PR artesunate, IV quinine, A/L	Black water fever
41 M, Nigerian	Nigeria	Pf	15.0	Severe	A/L	Black water fever
21 M, Japanese	Kenya	Pf	21.7	Severe	Quinine, clindamycin	Neurocognitive dysfunction
56 M, Japanese	Cote d'Ivoire	Pf	1.73	Non-severe	A/L	Glomerulonephritis
43 M, Japanese	Zambia	Pf	0.035	Severe	A/L	Cardiomyopathy, peripheral gangrene of foot

A/L = artemether/lumefantrine; F = female; M = male; IV = intravenous; PR = per rectum; Pf = Plasmodium falciparum.